Neoadjuvant immune checkpoint inhibitor treatment + chemotherapy (vs. chemotherapy alone) for locally advanced non‑small cell lung cancer: A retrospective cohort study

Neoadjuvant immune checkpoint inhibitor (ICI) treatment + chemotherapy has been used for locally advanced non-small cell lung cancer (NSCLC); however, evidence regarding the efficacy of this treatment is insufficient, particularly in Chinese patients. Therefore, the aim of the present study was to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yi, Liu, Zaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236247/
https://www.ncbi.nlm.nih.gov/pubmed/37274484
http://dx.doi.org/10.3892/ol.2023.13878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236247/
https://www.ncbi.nlm.nih.gov/pubmed/37274484
http://dx.doi.org/10.3892/ol.2023.13878

Ejemplares similares